CFO Taich Files To Sell 11,312 Of 10X Genomics Inc [TXG]

Taich Adam, Chief Financial Officer of 10X Genomics Inc [TXG], filed a Form 144 on November 24, 2025 with the Securities and Exchange Commission proposing to sell restricted securities:

Prior to the sale of restricted stock, owners must file a Form 144 with the SEC. Upon submission of the filing to the SEC the owner is permitted to sell the shares, or any fraction thereof, within 90 days.

For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.

Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.